• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ PANOPTIX TORIC TRIFOCAL IOL; LENS, MULTIFOCAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ PANOPTIX TORIC TRIFOCAL IOL; LENS, MULTIFOCAL Back to Search Results
Model Number TFNT30
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Blurred Vision (2137); Visual Impairment (2138); Balance Problems (4401)
Date of Event 12/08/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A surgeon reported that following an intraocular lens (iol) implant procedure, the patient is not happy with vision and complains of blurred vision at all distances and unsteadiness.The surgeon plans to exchange the lens for a monofocal iol.Information was received reporting the lens is to be exchanged due to "suspect image splitting and decreased contrast sensitivity." the patient also reported feeling "unbalanced." additional information has been requested.
 
Event or Problem Description
Further information was received indicating that the lens was exchanged in a secondary procedure.
 
Additional Manufacturer Narrative
The product was not returned.Product history records were reviewed and the documentation indicated the product met release criteria.The customer indicated the use of qualified associated products.The product investigation could not identify a root cause for the reported complaint.The difference in cylinder between the original implant lens model and the replacement lens model may suggest that the replacement lens model was an improved choice for the patient's vision needs.No additional information has been provided at this time.There are no other complaints in this lot.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ PANOPTIX TORIC TRIFOCAL IOL
Common Device Name
LENS, MULTIFOCAL
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
MDR Report Key11558146
Report Number1119421-2021-00629
Device Sequence Number14472077
Product Code MFK
UDI-Device Identifier00380652390040
UDI-Public00380652390040
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P040020
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date (Section B) 04/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/16/2025
Device Model NumberTFNT30
Device Catalogue NumberTFNT30.235
Device Lot Number15091394
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 03/23/2021
Supplement Date Received by Manufacturer03/23/2021
Initial Report FDA Received Date03/23/2021
Supplement Report FDA Received Date04/22/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
MONARCH III IOL CARTRIDGE D; MONARCH III IOL INJECTOR; PROVISC
Outcome Attributed to Adverse Event Other; Required Intervention;
Patient Age49 YR
-
-